173 related articles for article (PubMed ID: 37710961)
21. Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell-derived neural crest cells.
Mukae K; Takenobu H; Endo Y; Haruta M; Shi T; Satoh S; Ohira M; Funato M; Toguchida J; Osafune K; Nakahata T; Kanda H; Kamijo T
Cancer Sci; 2023 May; 114(5):1898-1911. PubMed ID: 36661413
[TBL] [Abstract][Full Text] [Related]
22. Myocardial Mycn is essential for mouse ventricular wall morphogenesis.
Harmelink C; Peng Y; DeBenedittis P; Chen H; Shou W; Jiao K
Dev Biol; 2013 Jan; 373(1):53-63. PubMed ID: 23063798
[TBL] [Abstract][Full Text] [Related]
23. Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities.
Mroske C; Rasmussen K; Shinde DN; Huether R; Powis Z; Lu HM; Baxter RM; McPherson E; Tang S
BMC Med Genet; 2015 Nov; 16():102. PubMed ID: 26542245
[TBL] [Abstract][Full Text] [Related]
24. Germline PTPN11 and somatic PIK3CA variant in a boy with megalencephaly-capillary malformation syndrome (MCAP)--pure coincidence?
Döcker D; Schubach M; Menzel M; Spaich C; Gabriel HD; Zenker M; Bartholdi D; Biskup S
Eur J Hum Genet; 2015 Mar; 23(3):409-12. PubMed ID: 24939587
[TBL] [Abstract][Full Text] [Related]
25. Function of Oncogene Mycn in Adult Neurogenesis and Oligodendrogenesis.
Chen J; Guan Z
Mol Neurobiol; 2022 Jan; 59(1):77-92. PubMed ID: 34625907
[TBL] [Abstract][Full Text] [Related]
26. Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation.
Newman EA; Chukkapalli S; Bashllari D; Thomas TT; Van Noord RA; Lawlor ER; Hoenerhoff MJ; Opipari AW; Opipari VP
Cell Death Dis; 2017 Dec; 8(12):3208. PubMed ID: 29238067
[TBL] [Abstract][Full Text] [Related]
27. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.
Huang R; Cheung NK; Vider J; Cheung IY; Gerald WL; Tickoo SK; Holland EC; Blasberg RG
FASEB J; 2011 Dec; 25(12):4138-49. PubMed ID: 21856782
[TBL] [Abstract][Full Text] [Related]
28. 2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.
Jeison M; Ash S; Halevy-Berko G; Mardoukh J; Luria D; Avigad S; Feinberg-Gorenshtein G; Goshen Y; Hertzel G; Kapelushnik J; Ben Barak A; Attias D; Steinberg R; Stein J; Stark B; Yaniv I
Am J Pathol; 2010 Jun; 176(6):2616-25. PubMed ID: 20395439
[TBL] [Abstract][Full Text] [Related]
29. Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis.
Mirzaa GM; Conway RL; Gripp KW; Lerman-Sagie T; Siegel DH; deVries LS; Lev D; Kramer N; Hopkins E; Graham JM; Dobyns WB
Am J Med Genet A; 2012 Feb; 158A(2):269-91. PubMed ID: 22228622
[TBL] [Abstract][Full Text] [Related]
30. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
[TBL] [Abstract][Full Text] [Related]
31. Feingold syndome: a rare but important cause of syndromic tracheoesophageal fistula.
Layman-Pleet L; Jackson CC; Chou S; Boycott KM
J Pediatr Surg; 2007 Sep; 42(9):E1-3. PubMed ID: 17848225
[TBL] [Abstract][Full Text] [Related]
32. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
[TBL] [Abstract][Full Text] [Related]
33. Variant type and position predict two distinct limb phenotypes in patients with GLI3-mediated polydactyly syndromes.
Baas M; Burger EB; van den Ouweland AM; Hovius SE; de Klein A; van Nieuwenhoven CA; Galjaard RJH
J Med Genet; 2021 Jun; 58(6):362-368. PubMed ID: 32591344
[TBL] [Abstract][Full Text] [Related]
34. A Feingold syndrome case with previously undescribed features and a new mutation.
Koçak H; Ozaydin E; Köse G; Marcelis CL; Kamsteeg EJ; Ceylaner S
Genet Couns; 2009; 20(3):261-7. PubMed ID: 19852433
[TBL] [Abstract][Full Text] [Related]
35. An immature, dedifferentiated, and lineage-deconstrained cone precursor origin of N-Myc-initiated retinoblastoma.
Singh HP; Shayler DWH; Fernandez GE; Thornton ME; Craft CM; Grubbs BH; Cobrinik D
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2200721119. PubMed ID: 35867756
[TBL] [Abstract][Full Text] [Related]
36. CCNB1IP1 prevents ubiquitination-mediated destabilization of MYCN and potentiates tumourigenesis of MYCN-amplificated neuroblastoma.
Zhou Y; Yan H; Zhou Q; Wang P; Yang F; Yuan Z; Du Q; Zhai B
Clin Transl Med; 2023 Jul; 13(7):e1328. PubMed ID: 37461251
[TBL] [Abstract][Full Text] [Related]
37. De novo heterozygous variants in SLC30A7 are a candidate cause for Joubert syndrome.
Penon-Portmann M; Eldomery MK; Potocki L; Marafi D; Posey JE; Coban-Akdemir Z; Harel T; Grochowski CM; Loucks H; Devine WP; Van Ziffle J; Doherty D; Lupski JR; Shieh JT
Am J Med Genet A; 2022 Aug; 188(8):2360-2366. PubMed ID: 35751429
[TBL] [Abstract][Full Text] [Related]
38. Copy number gain of MYCN gene is a recurrent genetic aberration and favorable prognostic factor in Chinese pediatric neuroblastoma patients.
Wang M; Zhou C; Cai R; Li Y; Gong L
Diagn Pathol; 2013 Jan; 8():5. PubMed ID: 23320395
[TBL] [Abstract][Full Text] [Related]
39. A new variant of MYCN gene as a cause of Feingold syndrome.
Zeka N; Bejiqi R; Gerguri A; Zogaj L; Jashari H
Clin Case Rep; 2022 May; 10(5):e05886. PubMed ID: 35620261
[TBL] [Abstract][Full Text] [Related]
40. The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress.
Petroni M; Sardina F; Heil C; Sahún-Roncero M; Colicchia V; Veschi V; Albini S; Fruci D; Ricci B; Soriani A; Di Marcotullio L; Screpanti I; Gulino A; Giannini G
Cell Death Differ; 2016 Feb; 23(2):197-206. PubMed ID: 26068589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
